Jonneh
Bluelighter
- Joined
- Jul 29, 2014
- Messages
- 274
Thanks. Frankly, I was sceptical that an effector like mTOR, which integrates so many intracellular signalling pathways, could form an axis underlying something as complex as depression. That's the big caveat of rodent models of highly nuanced and distinctly human disorders (it is depression we're talking about). I also get uncomfortable when spine growth and LTP are seen as 'good things' and 'memory promoting'. That's not how it works at all.
But fair enough, synaptogenesis is undoubtedly an important effect, whatever it is doing wherever they found it, and that ketamine acts through mTOR to effect this process is interesting, even surprising, since NMDA receptor-dependent synaptic and structural plasticity (like synapto-/spinogenesis) will probably be blocked (although there is controversy about that in the case of LTD).